LEIDEN JEFFREY M 4

What Happened
Jeffrey M. Leiden, Executive Chairman and Director of Vertex Pharmaceuticals (VRTX), disposed of 3,547 shares on 2026-02-24 as a payment to satisfy tax liability related to an equity award or option exercise. The shares were disposed at $485.11 per share for a gross value of approximately $1,720,685. This transaction is a routine tax-withholding disposition rather than an open-market sale for diversification or investment.

Key Details

• Transaction date: 2026-02-24; Filing date: 2026-02-26 (Form 4 accession 0001242825-26-000002).
• Price: $485.11 per share; Shares disposed: 3,547; Gross value: ~$1,720,685.
• Transaction code: F — payment of exercise price or tax liability (share withholding/disposition to cover taxes).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing timeliness: No late filing indication in the provided record.

Context
Code F transactions typically reflect withholding or disposition of shares to cover tax obligations from option exercises or vesting events (a form of "net settlement"). These are routine administrative actions and do not necessarily indicate insider sentiment about the company’s prospects.